JournalSpotting
JournalSpotting
#03 Covid Zone 1- Coronavirus literature updates 30th March 2020
Welcome to the COVID-ZONE.
Journalspotting is here to bring you important clinical updates on coronavirus.
Get in touch: journalspotting@gmail.com
Twitter @JournalSpotting
In today's episode:
#ACE inhibitors and angiotensin receptor blockers- do they worsen COVID-19?
https://doi.org/10.1016/j.cell.2020.02.052
ESC position statement
#The NSAID controversy
https://doi.org/10.1016/S2213-2600(20)30116-8
EMA statement
French pharmacovigilance of ibuprofen
MHRA alert
Indomethacin and SARS CoV-1
#Lopinavir/Ritonavir falls at the first hurdle
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2001282?articleTools=true
#Chloroquine/Hydroxychloroquine get a big endorsement
Systematic review on the efficacy and safety of chloroquine for treatment of COVID-19
Letter in Bioscience trends 10.5582/bst.2020.01047
In vitro study of chloroquine: https://www.nature.com/articles/s41422-020-0282-0
#How good are the swabs?
https://jamanetwork.com/journals/jama/fullarticle/2762997
#Anosmia is the new normal: Will I ever smell again?
https://www.entnet.org/content/coronavirus-disease-2019-resources
#Coronavirus likes plastic, hates pennies: which surfaces should I be wiping down?
https://pubmed.ncbi.nlm.nih.gov/32182409/
#Modelling studies that matter
https://www.bmj.com/content/bmj/368/bmj.m1216.full.pdf
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/
Oxford modelling
#Covert COVID Distractions
Because isolation can bring out a sense of humour in us, and we all need a distraction!
Visit the website on www.journalspotting.com.
Follow us on Twitter @JournalSpotting.
Email us on journalspotting@gmail.com.
Get our JournalClub App on https://journalclub.messly.com
Share us with all your colleagues!